Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis

by Eline Schillebeeckx, Jan P. van Meerbeeck, Kevin Lamote
Published 2021-11-01

European guidelines for the management of malignant pleural mesothelioma

by Eric van Thiel, Rabab Gaafar, Jan P. van Meerbeeck
Published 2011-10-01

Mesothelioma treatment: Are we on target? A review

by Birgitta I. Hiddinga, Christian Rolfo, Jan P. van Meerbeeck
Published 2015-05-01

Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research

by Eline Janssens, Eline Janssens, Zoë Mol, Lore Vandermeersch, Sabrina Lagniau, Sabrina Lagniau, Sabrina Lagniau, Karim Y. Vermaelen, Karim Y. Vermaelen, Karim Y. Vermaelen, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Christophe Walgraeve, Elly Marcq, Kevin Lamote, Kevin Lamote, Kevin Lamote
Published 2022-05-01

A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in Belgium

by Paloma Diab Garcia, Annemiek Snoeckx, Jan P. Van Meerbeeck, Guido Van Hal
Published 2022-12-01

A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck Neoplasms

by Heleen Konings, Sofie Stappers, Margot Geens, Benedicte Y. De Winter, Kevin Lamote, Kevin Lamote, Kevin Lamote, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Jan P. van Meerbeeck, Pol Specenier, Pol Specenier, Olivier M. Vanderveken, Olivier M. Vanderveken, Olivier M. Vanderveken, Kristien J. Ledeganck
Published 2020-06-01

Recent developments in the treatment of small cell lung cancer

by Birgitta I. Hiddinga, Jo Raskin, Annelies Janssens, Patrick Pauwels, Jan P. Van Meerbeeck
Published 2021-07-01

Investigational approaches for mesothelioma

by Veerle F Surmont, Eric RE van Thiel, Karim eVermaelen, Jan P Van Meerbeeck
Published 2011-08-01

Editorial: Imaging assessment of response to immunotherapy

by Mariaelena Occhipinti, Andrea R. Filippi, Andrea R. Filippi, Sean Walsh, Jan P. van Meerbeeck
Published 2023-01-01

Lung Cancer Screening: New Perspective and Challenges in Europe

by Jan P. Van Meerbeeck, Emma O’Dowd, Brian Ward, Paul Van Schil, Annemiek Snoeckx
Published 2022-05-01

Pleural Nodules and Mediastinal Lymphadenopathy in a Smoker: An Unusual Case Report

by Damien Desbuquoit, Stijn  Van Hecke, Pjotr Even, Paul M. Parizel, Jan P. van Meerbeeck, Annemie Snoeckx
Published 2016-08-01

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma

by Sophie Rovers, Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P. van Meerbeeck, Evelien Smits, Elly Marcq
Published 2022-03-01

Imaging of urgencies and emergencies in the lung cancer patient

by Bruno De Potter, Jef Huyskens, Birgitta Hiddinga, Maarten Spinhoven, Annelies Janssens, Jan P. van Meerbeeck, Paul M. Parizel, Annemie Snoeckx
Published 2018-04-01

Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology

by Annemie Snoeckx, Pieter Reyntiens, Damien Desbuquoit, Maarten J. Spinhoven, Paul E. Van Schil, Jan P. van Meerbeeck, Paul M. Parizel
Published 2017-11-01

Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology Patients

by Kurt G. Tournoy, Valerie Adam, Inge Muylle, Helene De Rijck, Ellen Everaert, Ehsan Eqlimi, Jan P. van Meerbeeck, Piet Vercauter
Published 2023-07-01

New Implications of Patients’ Sex in Today’s Lung Cancer Management

by Jo Raskin, Annemiek Snoeckx, Annelies Janssens, Charlotte De Bondt, Reinier Wener, Mick van de Wiel, Jan P. van Meerbeeck, Evelien Smits
Published 2022-07-01

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma

by Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, Jo Raskin, Joris Van Cleemput, Veerle F. Surmont, Kristiaan Nackaerts, Elly Marcq, Jan P. van Meerbeeck, Kevin Lamote
Published 2022-06-01

Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression

by Elly Marcq, Jonas RM Van Audenaerde, Jorrit De Waele, Julie Jacobs, Jinthe Van Loenhout, Glenn Cavents, Patrick Pauwels, Jan P van Meerbeeck, Evelien LJ Smits
Published 2019-08-01

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

by Elly Marcq, Jonas R. M. Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels, Jan P. van Meerbeeck, Scott A. Fisher, Evelien L. J. Smits
Published 2021-01-01

Lung cancer in Europe: The way forward

by Monica Racovita, Eleanor Wheeler, Suzanne Wait, Dani Bancroft, Rowan Eastabrook, Tit Albreht, Anne-Marie Baird, Jacek Jassem, Aoife E. McNamara, Silvia Novello, Cornel Radu-Loghin, Jan P. van Meerbeeck
Published 2022-02-01